Skip to main content

Global Single-use Bioprocessing Market Outlook & Forecast 2023-2028: New Product Launches & Increasing Strategic Acquisitions and Collaborations Spearheading Growth and Expansion -

The "Single-use Bioprocessing Market - Global Outlook & Forecast 2023-2028" report has been added to's offering.

The global single-use bioprocessing market is expected to reach a value of $26.54 billion by 2028 from $9 billion in 2022, growing at a CAGR of 19.74% from 2022 to 2028

The global single-use bioprocessing market is a thriving and dynamic sector that presents substantial growth opportunities for industry players. While the field boasts both global and local participants, a handful of major global companies hold significant market shares, offering a wide array of Single-Use Technologies (SUTs).

The promising growth prospects in this market are expected to attract new entrants, heightening competition. This intensified competition among SUT manufacturers is anticipated to drive substantial product innovations, including the development of large-capacity single-use bioreactors.

The North American single-use bioprocessing market is experiencing significant growth and is poised to maintain this momentum in the foreseeable future. Key drivers for this growth include the rising demand for biologics, particularly among the elderly population, substantial investments in Research and Development (R&D) by biopharmaceutical firms, and the patent expirations of biologic drugs.

North America, particularly the United States, is renowned for its in-house biopharmaceutical manufacturing facilities. This has bolstered the adoption of disposable components, both simple and advanced, within single-use systems, such as mixing systems, bioreactors, and cell culture systems, over recent years.

Market Trends & Drivers

New Product Launches: Technological advancements have played a pivotal role in the global expansion of single-use bioprocess consumables. Manufacturers in this sector have introduced innovative products that enhance the safety, ease, and efficiency of single-use bioprocessing. Such innovations enable companies to capture market share by aligning with market demands.

Increasing Strategic Acquisitions and Collaborations: The strategic acquisition of single-use technology can enhance its adoption across the biopharmaceutical industry. This technology is a cost-effective and efficient means to streamline operations, reduce waste, and enhance quality control. Strategic acquisitions of high-quality single-use technology can bolster an organization's competitive advantage while driving cost-efficiency and operational improvement.

Growing Biomanufacturing Capacity and Biopharmaceutical Uptake: The expanding biomanufacturing capacity and the increasing demand for biopharmaceuticals and biosimilars are pivotal drivers of the single-use bioprocessing market. This technology offers a versatile platform for producing various biopharmaceuticals, biotherapeutics, vaccines, monoclonal antibodies, and biosimilars.

Advancements in biomanufacturing have made single-use bioprocessing more flexible, efficient, and scalable. It reduces capital costs, shortens process times, and mitigates product contamination risks. Moreover, it eliminates the need for extensive equipment cleaning and sterilization, resulting in cost savings and operational efficiency gains.

In summary, the single-use bioprocessing market is evolving rapidly, with trends and drivers like new product launches, strategic acquisitions, and growing biomanufacturing capacity fueling its growth and expansion. Companies in this sector are poised to benefit from these developments by aligning their strategies with these market dynamics.



Single-use bioprocessing equipment is a technology that has revolutionized the biopharmaceutical industry.

This technology has increased efficiency, flexibility, safety, and cost savings during bioprocessing. Single-use bioprocessing equipment is a system of technologies designed to replace reusable stainless steel and other materials traditionally used in bioprocessing.

This equipment uses single-use components, including bags, bioreactors, tubing, syringes, connectors, and filters, disposed of after use. In 2022, the single-use bioprocessing equipment product type held a larger share of the global single-use bioprocessing market.


The global single-use bioprocessing market by application is segmented as monoclonal antibodies (mABs), vaccines, cell therapies, and others.

Monoclonal antibodies (mABs) hold the largest industry share by application segment. Single-use bioprocessing is an emerging technology in the biopharmaceutical industry that has revolutionized how monoclonal antibodies (mAbs) are produced. Single-use bioprocessing involves using disposable bioreactors and other components to produce proteins, such as mAbs.

Unlike traditional stainless-steel bioreactors, single-use bioreactors can be quickly set up, require minimal cleaning, and reduce the risk of cross-contamination. Due to their complexity and high cost, these advantages make single-use bioprocessing particularly attractive for mAb production.


The biopharmaceutical manufacturers segment accounted for over 39% of the global single-use bioprocessing market.

This segment dominates the overall market and will likely retain its dominance in the coming years due to its widespread adoption in research and commercial manufacturing applications. Several biopharmaceutical manufacturers have already explored SUB solutions usage in commercial manufacturing.

However, their potential benefits are significant, particularly in small-volume manufacturing in modular facilities. Most biopharmaceutical manufacturers, especially large and medium-sized companies, spend over $50 million on equipment annually. It has been witnessed that a high percentage of capital is being spent on single-use bioprocessing by biopharmaceutical manufacturers.


The global single-use bioprocessing market by the method is categorized as filtration, storage & transport, cell culture, mixing, and purification. Filtration holds the largest share of the market. Single-use bioprocessing is a method of filtration that has grown increasingly popular in the biotechnology industry.

It involves using disposable, self-contained systems to prepare, filter, and process bioproducts. This form of filtration has many advantages, especially for pharmaceutical and biological product manufacturing. Single-use bioprocessing has revolutionized the biotechnology industry. This reduces the need for traditional equipment and infrastructure, resulting in cost savings and improved production efficiency.


The upstream workflow segment dominated the global single-use bioprocessing market. Upstream single-use bioprocessing workflow is focused on upstream unit operations such as cell culture, protein expression, and harvest.

Over the last decade, advances in this workflow have enabled biopharmaceutical companies to streamline the process, increase product yields, and reduce costs. The upstream single-use bioprocessing workflow advancements have provided biopharmaceutical companies with a more efficient and cost-effective workflow.

Market Opportunities & Trends

  • Single-Use Technology in Cell and Gene Therapy
  • Increasing Demand for Continuous Bioprocessing
  • Technological Advances in Single-Use Bioprocessing (Sub)
  • New Product Launches
  • Increasing Strategic Acquisitions and Collaborations

Market Growth Enablers

  • Growing Biomanufacturing Capacity and Uptake of Biopharmaceuticals & Biosimilars
  • Lower Capital Investment in Suts Over Multi-Use Platforms and Less Floor Space Requirements
  • Increased Acceptance of Sus to Enhance Biomanufacturing Productivity and Efficiency
  • Reduced Water Consumption and Lesser Environmental Impact of Single-Use Technologies

Market Restraints

  • The Changing Scale of Single-Use Operations
  • Low Strength of Supply Chain and Lack of Standardization
  • Issues Related to Leachables and Extractables

Key Company Profiles

  • Thermo Fisher Scientific
  • Sartorius Stedim Biotech
  • Danaher
  • Merck KGaA
  • Avantor

Other Prominent Vendors

  • 3i Group
  • 3M
  • ABEC
  • Adolf Kuhner
  • AdvantaPure
  • Barry-Wehmiller Companies
  • Broadley-James
  • Celltainer Biotech
  • CerCell A/S
  • CESCO Bioengineering
  • Charter Medical
  • Colder Products Company
  • Corning
  • Distek
  • DrM, Dr. Mueller
  • Emerson Electric
  • Entegris
  • Eppendorf
  • Foxx Life Sciences
  • Getinge
  • Holland Applied Technologies
  • Lonza
  • New Horizon Biotech
  • OmniBRx Biotechnologies
  • PendoTECH
  • PBS Biotech
  • Repligen
  • Saint-Gobain
  • Sentinel Process Systems
  • Solaris Biotechnology
  • Watson-Marlow Fluid Technology Solutions
  • Weigao Group
  • W.L. Gore & Associates

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Laura Wood, Senior Press Manager

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.